About Gerresheimer AG (GXI)
Gerresheimer AG is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Düsseldorf, Germany. GXI has been publicly traded since 2007, giving it 19+ years of trading history.
Gerresheimer AG (GXI) has been publicly traded since 2007, making it a 19-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Düsseldorf, Germany and employs approximately 13,535 people. With a market capitalization of €610 million, GXI is a smaller company with higher growth potential.
GXI trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a small-cap-cap stock with a market capitalization of approximately €610 million. The company employs approximately 13,535 people worldwide.
Key Statistics
- Current Price
- €17.67
- Market Cap
- €610.32M
- 52-Week High
- €80.80
- 52-Week Low
- €14.83
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
GXI Investment Performance
GXI has declined 35.9% year-to-date in 2026. Over the past 5 years, a €1,000 investment in GXI would have grown to €220, representing a -78.0% total return. Since its IPO in 2007, a €1,000 investment would now be worth €589.
€1,000 Invested in Gerresheimer AG (GXI)
How much would €1,000 invested in GXI be worth today?
What would €1,000 invested in GXI 1 year ago be worth today?
A €1,000 investment in Gerresheimer AG (GXI) in 2025 would be worth €252 as of March 2026, representing a -74.8% total return.
What would €1,000 invested in GXI 3 years ago be worth today?
A €1,000 investment in Gerresheimer AG (GXI) in 2023 would be worth €199 as of March 2026, representing a -80.1% total return.
What would €1,000 invested in GXI 5 years ago be worth today?
A €1,000 investment in Gerresheimer AG (GXI) in 2021 would be worth €220 as of March 2026, representing a -78.0% total return.
What would €1,000 invested in GXI 10 years ago be worth today?
A €1,000 investment in Gerresheimer AG (GXI) in 2016 would be worth €293 as of March 2026, representing a -70.8% total return.
What would €1,000 invested in GXI at IPO be worth today?
A €1,000 investment in Gerresheimer AG (GXI) at IPO would be worth €589 as of March 2026, representing a -41.1% total return.
Monthly Returns Heatmap
Over the past 18+ years (225 months), Gerresheimer AG (GXI) has averaged a monthly return of +0.18% with a median return of +0.31%. The stock had 117 positive months (52%) and 105 negative months (47%). The best month in GXI's history was April 2009 with a +35.2% return, while the worst was February 2026 at -32.8%. Historically, April tends to be the strongest month (averaging +5.1%), and September the weakest (-4.0%).
GXI's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2015 with a cumulative return of +51.9%, and the worst was 2025 at -81.5%.
Annual Returns
Over 19 years of trading history, Gerresheimer AG (GXI) has delivered an average annual return of +3.22% with a median return of -0.91%. The compound annual growth rate (CAGR) is -2.74%. The stock posted gains in 8 years (42%) and losses in 11 years (58%).
GXI's best year was 2015 with a +63.01% gain, while the worst was 2025 at -61.12%. The longest streak of consecutive positive years was 2, and the longest losing streak was 3 years. GXI achieved double-digit gains (10%+) in 8 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -35.93% | €27.58 | €17.67 |
| 2025 | -61.12% | €70.94 | €27.58 |
| 2024 | -23.86% | €93.17 | €70.94 |
| 2023 | +51.98% | €61.30 | €93.17 |
| 2022 | -24.56% | €81.26 | €61.30 |
| 2021 | -2.15% | €83.04 | €81.26 |
| 2020 | +29.08% | €64.33 | €83.04 |
| 2019 | +22.75% | €52.41 | €64.33 |
| 2018 | -15.79% | €62.24 | €52.41 |
| 2017 | -0.67% | €62.66 | €62.24 |
| 2016 | -0.92% | €63.24 | €62.66 |
| 2015 | +63.01% | €38.79 | €63.24 |
| 2014 | -10.28% | €43.24 | €38.79 |
| 2013 | +28.71% | €33.59 | €43.24 |
| 2012 | +26.72% | €26.51 | €33.59 |
| 2011 | -0.91% | €26.75 | €26.51 |
| 2010 | +40.38% | €19.06 | €26.75 |
| 2009 | +23.16% | €15.48 | €19.06 |
| 2008 | -48.35% | €29.96 | €15.48 |
GXI Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Gerresheimer AG as an investment
Valuation
GXI currently trades at a trailing P/E ratio of 26.0, which is considered high relative to the broader market. The forward P/E of 6.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 0.4. The price-to-sales ratio is 0.3.
Dividends
Gerresheimer AG pays a dividend to shareholders with a current yield of 0.23%. This translates to €0.04 per share annually. The payout ratio of 6% indicates sustainable dividend coverage.
Risk & Volatility
GXI has a beta of 0.57, indicating it is less volatile than the overall market. The stock's 52-week range is €14.83 to €80.80, and it currently trades near its 52-week low.
Analyst Ratings
Based on 11 analyst opinions, GXI has a consensus "hold" rating. The average price target of €24.40 suggests 38.1% upside from current levels.
Frequently Asked Questions: GXI
What sector is GXI in? ▼
GXI operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has GXI performed historically? ▼
Over 19 years of trading history, GXI has posted gains in 8 years (42% of the time). The best year was 2015 with a +63.0% return. Past performance does not guarantee future results.
How can I invest in GXI? ▼
You can invest in GXI through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold GXI.
Does GXI pay dividends? ▼
Gerresheimer AG pays a dividend to shareholders with a current yield of 0.23%. This translates to €0.04 per share annually. The payout ratio of 6% indicates sustainable dividend coverage.
What does Gerresheimer AG do? ▼
Gerresheimer AG is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Düsseldorf, Germany.
What sector is GXI in? ▼
GXI operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did GXI go public? ▼
Gerresheimer AG went public in 2007, making it a 19-year-old public company as of 2026.
How much would €1,000 invested in GXI 5 years ago be worth today? ▼
A €1,000 investment in GXI five years ago would be worth approximately €220 today, representing a -78.0% return.
How much would €1,000 invested in GXI 10 years ago be worth today? ▼
A €1,000 investment in GXI ten years ago would be worth approximately €292 today, representing a -70.8% total return over the decade.
What is GXI's 3-year return? ▼
Over the past 3 years, GXI has returned -80.1%. A €1,000 investment would have grown to €199.
How much would €1,000 invested in GXI at IPO be worth today? ▼
If you invested €1,000 in GXI at its IPO in 2007, it would be worth approximately €589 today, a -41.1% return over 19 years.
Does GXI pay dividends? ▼
Yes, Gerresheimer AG pays a dividend with a current yield of 0.23%, which is €0.04 per share annually.
What is GXI's market cap? ▼
Gerresheimer AG has a market capitalization of €610 million, classifying it as a small-cap company.
What is GXI's P/E ratio? ▼
GXI has a trailing P/E ratio of 26.0 and a forward P/E of 6.3, which measures how much investors are paying per dollar of earnings.
Is GXI a buy, hold, or sell? ▼
Based on 11 opinions, GXI has a consensus "hold" rating. The average price target is €24.4.
Last updated: 3/15/2026